Product Information

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB is a generic product labeled by Strides Pharma Inc., priced at $4.9435 per EA under NDC 64380019901. Its NADAC has been published 124 times since May 22, 2024.

FDA first approved this application on Jun 1, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB

amlodipine besylate valsartan hydrochlorothiazide
$4.9435per EA

Strength

10; 12.5; 160 mg/1; mg/1; mg/1

NDC

64380019901

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA201087

FDA Approved

6/1/2015

TE Code

AB

On Market Since

6/27/2022

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB has been published 124 times since May 22, 2024, and over the history we have for it it has declined 32.9%. The table below summarizes its recorded NADAC range and movement.

Current price$4.9435 per EA
All-time high$8.3945 (Aug 13, 2025)
All-time low$4.9435 (Sep 23, 2026)
52-week high$8.3756
52-week low$4.9435
Median price$7.7294
Average price$7.3600
Largest weekly change-11.9% (May 20, 2026)
Weeks tracked124
Tracking sinceMay 22, 2024

Price History

1W

0.0%

1M

-1.4%

3M

-6.8%

6M

-32.4%

1Y

-41.0%

3Y

N/A

5Y

N/A

All

-32.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine besylate valsartan hydrochlorothiazide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB, manufactured by Strides Pharma Inc., is $4.9435 per EA (NDC 64380019901), effective Sep 30, 2026.

How has the price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB has declined 32.9%. It has been tracked across 124 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB?

Since May 22, 2024, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB has ranged from a low of $4.9435 (Sep 23, 2026) to a high of $8.3945 (Aug 13, 2025), with a median of $7.7294 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB?

AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-12.5 MG TAB (NDC 64380019901) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.